Novel Supreme DES Shows Results Comparable to Xience, Promus DES
A novel biodegradable-polymer-coated drug-eluting stent (DES) was found to be as safe and effective as the contemporary polymer-based DES in patients with acute coronary syndromes (ACS) and chronic coronary syndromes (CCS) undergoing percutaneous coronary intervention (PCI), according to late-breaking trial results presented Sunday at the American Heart Association Scientific Sessions 2020 virtual conference.